Literature DB >> 6712963

Studies on the activation of the enzymatic hydrolysis of sphingomyelin liposomes.

A Poulos, E Ranieri, P Shankaran, J W Callahan.   

Abstract

Two pH optima were observed for the hydrolysis of sphingomyelin liposomes by brain and fibroblast extracts; one at pH 4.2-4.5, the other at pH 7-8. The proportion of the acidic activity in fibroblasts was affected greatly by the culturing conditions. Both the acidic and neutral enzyme activities were deficient in Niemann-Pick Type A fibroblasts, suggesting that both were genetically related. Partially purified activators from normal as well as Gaucher disease spleen stimulated the hydrolysis of sphingomyelin, at both pH values, by fibroblast and brain extracts. After further purification by DE-52 and Sephacryl 200 column chromatography the Gaucher activator retained its ability to stimulate sphingomyelinase and was active as well towards beta-glucocerebrosidase and beta-galactocerebrosidase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712963     DOI: 10.1016/0005-2760(84)90315-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

Review 1.  Enzyme-replacement therapy: problems and prospects.

Authors:  B Rademaker; J Raber
Journal:  Pharm Weekbl Sci       Date:  1989-10-20

2.  Glucosylceramide and the level of the glucosidase-stimulating proteins.

Authors:  S C Datta; N S Radin
Journal:  Lipids       Date:  1986-11       Impact factor: 1.880

3.  Assignment of the gene for human sphingolipid activator protein-2 (SAP-2) to chromosome 10.

Authors:  S Fujibayashi; F T Kao; C Jones; H Morse; M Law; D A Wenger
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

4.  Analysis of the multiple forms of Gaucher spleen sphingolipid activator protein 2.

Authors:  B C Paton; A Poulos
Journal:  Biochem J       Date:  1988-08-15       Impact factor: 3.857

5.  Preliminary evidence for a processing error in the biosynthesis of Gaucher activator in mucolipidosis disease types II and III.

Authors:  E Ranieri; B Paton; A Poulos
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

6.  Effect of saposins on acid sphingomyelinase.

Authors:  M Tayama; S Soeda; Y Kishimoto; B M Martin; J W Callahan; M Hiraiwa; J S O'Brien
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

7.  Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.

Authors:  B Schmid; B C Paton; K Sandhoff; K Harzer
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

8.  Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase.

Authors:  B C Paton; B Schmid; B Kustermann-Kuhn; A Poulos; K Harzer
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

9.  Uptake and degradation of several pyrenesphingomyelins by skin fibroblasts from control subjects and patients with Niemann-Pick disease. Effect of the structure of the fluorescent fatty acyl residue.

Authors:  T Levade; S Gatt; R Salvayre
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

Review 10.  Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses.

Authors:  K Harzer; B C Paton; A Poulos; B Kustermann-Kuhn; W Roggendorf; T Grisar; M Popp
Journal:  Eur J Pediatr       Date:  1989-10       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.